Pharmaceuticals, Biotechnology and Life Sciences
Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of…
GUANGZHOU, China, Dec. 31, 2024 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a…
Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) — Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) (the “Company”), a company…
PRINCETON, N.J., Dec. 30, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that…
WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization…
MELBOURNE, Australia and BRUSSELS, Dec. 31, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company)…
DALLAS, Dec. 30, 2024 (GLOBE NEWSWIRE) — The 2024 Rising Stars of the life sciences and healthcare innovation sector took…
Current Renovaro Chairman to Lead Subsidiary’s Development Program and Commercialization LOS ANGELES and AMSTERDAM, Dec. 30, 2024 (GLOBE NEWSWIRE) —…
Scilex notified NASDAQ on December 30, 2024 that it has set a new record date of January 28, 2025 (the…
TUSTIN, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics…